Waters Corp. (WAT) shares plunged 11.63 percent to $311.86 on Monday after the company announced a $17.5 billion Reverse Morris Trust transaction with Becton, Dickinson and Company, merging BD's Biosciences & Diagnostic Solutions business with Waters.
The stock opened at $317.52 and fell as low as $302.45 during the session, with a high of $326.57. Trading volume surged to nearly 2 million shares, well above the daily average of 491,436. Waters now trades near the lower end of its 52-week range of $297.14 to $423.56, as investors react to the scale and complexity of the integration.
The strategic deal aims to form a life science and diagnostics leader with expanded technologies, recurring revenue streams, and a total addressable market of $40 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.